Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion. Issue 1 (January 2017)

• Record Type: Journal Article
• Authors: Diener, HC; Bernstein, R; Butcher, K; Campbell, B; Cloud, G; Davalos, A; Davis, S; Ferro, JM; Grond, M; Krieger, D; Ntaios, G; Slowik, A; Touzé, E
• Is Part Of: International journal of stroke. Volume 12:Issue 1(2017)
• Page Start: 9
• Page End: 12
• Publication Date: 2017-01
• Subjects: Ischemic stroke -- thrombolysis -- rt-PA -- thrombectomy -- dabigatran -- idarucizumab; 616.8005
• DOI: 10.1177/1747493016669849
• Languages: English
• ISSNs: 1747-4930

Abstract

Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed by rt-PA and/or thrombectomy in patients with ischemic stroke pre-treated with dabigatran. The use of idarucizumab followed by rt-PA is covered by the label of both drugs.